William A. Osborn's most recent trade in Abbott Laboratories was a trade of 8,106 Option (right to buy) done . Disclosure was reported to the exchange on April 29, 2022.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Abbott | William A. Osborn | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Apr 2022 | 8,106 | 8,106 | - | - | Option (right to buy) | |
| Abbott | William A. Osborn | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Apr 2022 | 1,602 | 98,598 (0%) | 0% | 0 | Common shares without par value | |
| Abbott | William A. Osborn | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 26 Oct 2021 | 15,752 | 0 | - | - | Option (right to buy) | |
| Abbott | William A. Osborn | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 59.42 per share. | 26 Oct 2021 | 15,752 | 96,996 (0%) | 0% | 59.4 | 935,984 | Common shares without par value |